top of page
The Professional Network for Healthcare Experts
Karyopharm plans Ayrmid merger through Chapter 11 restructuring with $55 million financing commitment
Karyopharm Therapeutics has announced a proposed merger with Ayrmid through a court-supervised Chapter 11 restructuring process, supported by a $55 million additional financing commitment.
nuaxia
2 days ago2 min read
Supernus and Indivior complete merger to create diversified CNS biopharmaceutical company
Supernus and Indivior have completed a merger of equals, creating a diversified central nervous system biopharmaceutical company with an 11-product portfolio spanning addiction treatment, psychiatry and neurology.
nuaxia
4 days ago2 min read
bottom of page